2seventy bio Current Cash

The latest current cash for TSVT is $92M as of March 2025. That compares with $57M in the prior-year period — up 62.6% year over year. Investors often review this figure alongside 2seventy bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, TSVT's current cash moved from $57M to $92M — a 62.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 2seventy bio's operating scale or balance-sheet position.

A current cash figure of $92M for TSVT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TSVT's current cash ($92M), review year-over-year change from $57M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.